Report Detail

Other Global CMO/CDMO Market Size, Status and Forecast 2019-2025

  • RnM3346676
  • |
  • 23 April, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
In 2018, the global CMO/CDMO market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CMO/CDMO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CMO/CDMO development in United States, Europe and China.

The key players covered in this study
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried

Market segment by Type, the product can be split into
Development
API production
Formulation

Market segment by Application, split into
Pharmaceutical Industry
Biotechnology
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CMO/CDMO status, future forecast, growth opportunity, key market and key players.
To present the CMO/CDMO development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CMO/CDMO are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global CMO/CDMO Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Development
      • 1.4.3 API production
      • 1.4.4 Formulation
    • 1.5 Market by Application
      • 1.5.1 Global CMO/CDMO Market Share by Application (2014-2025)
      • 1.5.2 Pharmaceutical Industry
      • 1.5.3 Biotechnology
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 CMO/CDMO Market Size
    • 2.2 CMO/CDMO Growth Trends by Regions
      • 2.2.1 CMO/CDMO Market Size by Regions (2014-2025)
      • 2.2.2 CMO/CDMO Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 CMO/CDMO Market Size by by Players
      • 3.1.1 Global CMO/CDMO Revenue by by Players (2014-2019)
      • 3.1.2 Global CMO/CDMO Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global CMO/CDMO Market Concentration Ratio (CR5 and HHI)
    • 3.2 CMO/CDMO Key Players Head office and Area Served
    • 3.3 Key Players CMO/CDMO Product/Solution/Service
    • 3.4 Date of Enter into CMO/CDMO Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global CMO/CDMO Market Size by Type (2014-2019)
    • 4.2 Global CMO/CDMO Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States CMO/CDMO Market Size (2014-2019)
    • 5.2 CMO/CDMO Key Players in United States
    • 5.3 United States CMO/CDMO Market Size by Type
    • 5.4 United States CMO/CDMO Market Size by Application

    6 Europe

    • 6.1 Europe CMO/CDMO Market Size (2014-2019)
    • 6.2 CMO/CDMO Key Players in Europe
    • 6.3 Europe CMO/CDMO Market Size by Type
    • 6.4 Europe CMO/CDMO Market Size by Application

    7 China

    • 7.1 China CMO/CDMO Market Size (2014-2019)
    • 7.2 CMO/CDMO Key Players in China
    • 7.3 China CMO/CDMO Market Size by Type
    • 7.4 China CMO/CDMO Market Size by Application

    8 Japan

    • 8.1 Japan CMO/CDMO Market Size (2014-2019)
    • 8.2 CMO/CDMO Key Players in Japan
    • 8.3 Japan CMO/CDMO Market Size by Type
    • 8.4 Japan CMO/CDMO Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia CMO/CDMO Market Size (2014-2019)
    • 9.2 CMO/CDMO Key Players in Southeast Asia
    • 9.3 Southeast Asia CMO/CDMO Market Size by Type
    • 9.4 Southeast Asia CMO/CDMO Market Size by Application

    10 India

    • 10.1 India CMO/CDMO Market Size (2014-2019)
    • 10.2 CMO/CDMO Key Players in India
    • 10.3 India CMO/CDMO Market Size by Type
    • 10.4 India CMO/CDMO Market Size by Application

    11 Central & South America

    • 11.1 Central & South America CMO/CDMO Market Size (2014-2019)
    • 11.2 CMO/CDMO Key Players in Central & South America
    • 11.3 Central & South America CMO/CDMO Market Size by Type
    • 11.4 Central & South America CMO/CDMO Market Size by Application

    12 International Players Profiles

    • 12.1 Recipharm
      • 12.1.1 Recipharm Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 CMO/CDMO Introduction
      • 12.1.4 Recipharm Revenue in CMO/CDMO Business (2014-2019)
      • 12.1.5 Recipharm Recent Development
    • 12.2 AMRI3
      • 12.2.1 AMRI3 Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 CMO/CDMO Introduction
      • 12.2.4 AMRI3 Revenue in CMO/CDMO Business (2014-2019)
      • 12.2.5 AMRI3 Recent Development
    • 12.3 Patheon
      • 12.3.1 Patheon Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 CMO/CDMO Introduction
      • 12.3.4 Patheon Revenue in CMO/CDMO Business (2014-2019)
      • 12.3.5 Patheon Recent Development
    • 12.4 Aenova
      • 12.4.1 Aenova Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 CMO/CDMO Introduction
      • 12.4.4 Aenova Revenue in CMO/CDMO Business (2014-2019)
      • 12.4.5 Aenova Recent Development
    • 12.5 Catalent
      • 12.5.1 Catalent Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 CMO/CDMO Introduction
      • 12.5.4 Catalent Revenue in CMO/CDMO Business (2014-2019)
      • 12.5.5 Catalent Recent Development
    • 12.6 Amatsigroup
      • 12.6.1 Amatsigroup Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 CMO/CDMO Introduction
      • 12.6.4 Amatsigroup Revenue in CMO/CDMO Business (2014-2019)
      • 12.6.5 Amatsigroup Recent Development
    • 12.7 WuXi PharmaTech
      • 12.7.1 WuXi PharmaTech Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 CMO/CDMO Introduction
      • 12.7.4 WuXi PharmaTech Revenue in CMO/CDMO Business (2014-2019)
      • 12.7.5 WuXi PharmaTech Recent Development
    • 12.8 Strides Shasun
      • 12.8.1 Strides Shasun Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 CMO/CDMO Introduction
      • 12.8.4 Strides Shasun Revenue in CMO/CDMO Business (2014-2019)
      • 12.8.5 Strides Shasun Recent Development
    • 12.9 Piramal
      • 12.9.1 Piramal Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 CMO/CDMO Introduction
      • 12.9.4 Piramal Revenue in CMO/CDMO Business (2014-2019)
      • 12.9.5 Piramal Recent Development
    • 12.10 Siegfried
      • 12.10.1 Siegfried Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 CMO/CDMO Introduction
      • 12.10.4 Siegfried Revenue in CMO/CDMO Business (2014-2019)
      • 12.10.5 Siegfried Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on CMO/CDMO. Industry analysis & Market Report on CMO/CDMO is a syndicated market report, published as Global CMO/CDMO Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of CMO/CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,077.10
      4,615.65
      6,154.20
      3,701.10
      5,551.65
      7,402.20
      608,829.00
      913,243.50
      1,217,658.00
      329,433.00
      494,149.50
      658,866.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report